
The Carlton Maddrey Wilson Memorial Research Grant
Contributed by: Deborah Wilson and Children
This grant was established in 2011.
Prion diseases are rare neurodegenerative conditions affecting humans and other mammals. These pathologies can be transmitted via genetic or infectious routes and are responsible for the epidemics of bovine spongiform encephalopathy, also known as mad cow disease, which mainly affected Europe in the late 1990s. Prion diseases are caused by the conversion of a normal protein, called the cellular prion protein (abbreviated PrP), into an aberrant form, called the scrapie prion protein (abbreviated PrPSc). Once formed, PrPSc behaves like an infectious agent (prion), propagating by inducing the conversion of additional PrP molecules, accumulating in large aggregates in brain tissues, and ultimately damaging the nervous system. While no cures are currently available for these disorders, recent evidence has provided strong support for the idea of lowering the expression of the normal form of PrP to treat prion diseases. We have recently developed a new technology, called PPI-FIT, for identifying drugs capable of selectively lowering the expression of target proteins. Thanks to PPI-FIT, we have identified a promising molecule able to reduce PrP levels and block prion replication in cells. However, the compound must be further developed to improve its pharmacological properties and make it safely administrable to humans. The project intends to directly pursue these tasks, with the ultimate goal to define a novel pharmacological option to test in prion disease patients.
Emiliano Biasini, PhD
Dulbecco Telethon Laboratory of Prions and Amyloids, Department of Cellular, Computational & Integrative Biology (CIBIO), University of Trento, Italy
Dr. Biasini is currently an Associate professor at the University of Trento. He devoted his entire career to studying prions and prion diseases. His laboratory is trying to explore new experimental avenues to identify treatments for prion diseases.
Author of 55 papers in international scientific journals and inventor of 3 patents about therapeutics and drug-discovery approaches for neurodegenerative diseases. Co-founder and scientific advisor at Sibylla Biotech (www.sibyllabiotech.it).
Contributed by: Deborah Wilson and Children
This grant was established in 2011.
Contributed by: The Snively Family
This grant was established in 2015.
Contributed by: Linda Parrish
This grant was established in 2015.
Contributed by: Ronda Fansler
This grant was established in 2015.
Contributed by: Lavonne C. Hall
Established in 2021.
Contributed by: Tom Fabian
Established in 2021.
This website was made possible by a generous donation from Cookie Stivison, in memory of her husband Tom Stivison, and a grant from the Centers for Disease Control and Prevention.